摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-喹喔啉基亚甲基)肼基甲酸甲酯 | 55456-55-8

中文名称
3-(2-喹喔啉基亚甲基)肼基甲酸甲酯
中文别名
脱氧卡巴氧/脱氧卡巴多司;脱氧卡巴氧
英文名称
methyl 3-(2-quinoxalinylmethylene)carbazate
英文别名
quinoxalin-2-ylmethylene-hydrazinecarboxylic acid methyl ester;Desoxycarbadox;methyl N-(quinoxalin-2-ylmethylideneamino)carbamate
3-(2-喹喔啉基亚甲基)肼基甲酸甲酯化学式
CAS
55456-55-8
化学式
C11H10N4O2
mdl
——
分子量
230.226
InChiKey
SOEMFPLGOUBPJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    232-236 °C(Solv: toluene (108-88-3); ethanol (64-17-5))
  • 密度:
    1.31±0.1 g/cm3(Predicted)
  • 溶解度:
    可溶于DMSO(轻微)、甲醇(轻微、加热)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    76.5
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 危险品标志:
    F,T
  • 安全说明:
    S45,S53
  • 危险类别码:
    R45,R11,R22
  • WGK Germany:
    3

SDS

SDS:1604dd3473eb2ca29e56d5c1f3554667
查看

制备方法与用途

生物活性

Desoxycarbadox 是 Carbadox(HY-B1340)的代谢产物。Carbadox 是一种喹喔啉二氮氧化物抗生素化合物。

体内研究

Desoxycarbadox 在大鼠中的瘤形成活性中扮演着重要角色。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    卡巴多盐酸 、 titanium(III) chloride 作用下, 以 乙腈 为溶剂, 反应 1.0h, 以94%的产率得到3-(2-喹喔啉基亚甲基)肼基甲酸甲酯
    参考文献:
    名称:
    Applications of TiCl3 as a Diagnostic Reagent for the Detection of Nitro- and N-Oxide-Containing Compounds as Potentially Mutagenic Impurities Using Ultrahigh-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry
    摘要:
    The ICH has strict guidelines for limiting the presence of potentially mutagenic impurities (PMIs) in marketed drugs. Therefore, it is important to fully characterize and quantitate all possible PMIs that could arise during the process of synthesizing and developing a drug. Two important and prevalent examples of PMIs are compounds containing N-oxide and nitro functional groups. TiCl3 derivatization is an established method for determining the presence or absence of N-oxide metabolites by reduction to the corresponding amine. In this study, we demonstrate a novel application of TiCl3 reduction combined with high-resolution UHPLC/HRMS to analyze PMIs. The results indicate that a variety of N-oxide- and nitro-containing compounds can be readily characterized by this facile platform method. In addition, we show that this chemical derivatization method can be utilized to enhance the ionization of nitro-containing compounds for LC/MS analysis.
    DOI:
    10.1021/acs.oprd.5b00312
点击查看最新优质反应信息

文献信息

  • Selective Monodeoxygenation of Methyl 3-(2-Quinoxalinylmethylene)carbazate N1, N4-Dioxide (Carbadox)
    作者:D. J. R. Massy、A. McKillop
    DOI:10.1055/s-1996-4420
    日期:1996.12
    The veterinary drug methyl 3-(2-quinoxalinylmethylene)carbazate N 1, N 4-dioxide (Carbadox) has been selectively reduced in good yield at either N 1 or N 4 with the reagents sodium dithionite or phosphorus trichloride, respectively. The identity of the products, which are important metabolites, was established by 1H NMR and by an X-ray crystal structure of the N 1-monodeoxygenated product. The further metabolite, bis(desoxy) Carbadox, was prepared by reduction of Carbadox with a slight excess of sodium dithionite/acetic acid. When a large excess of this reagent was used, a new compound, methyl 3-(2-quinoxalinylmethyl)carbazate, was also formed.
    兽药 3-(2-喹喔啉基亚甲基)咔唑酸甲酯 N 1、N 4-二氧化物(Carbadox)分别在 N 1 或 N 4 处用二亚硫酸钠或三氯化磷试剂进行了选择性还原,收率很高。通过 1H NMR 和 N 1-单脱氧产物的 X 射线晶体结构,确定了重要代谢产物的身份。另一种代谢物--双(脱氧)卡巴多,是用少量过量的二亚硫酸钠/乙酸还原卡巴多制备的。当使用大量过量的这种试剂时,还会生成一种新的化合物,即 3-(2-喹喔啉基甲基)咔唑酸甲酯。
  • Applications of TiCl<sub>3</sub> as a Diagnostic Reagent for the Detection of Nitro- and <i>N</i>-Oxide-Containing Compounds as Potentially Mutagenic Impurities Using Ultrahigh-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry
    作者:Rong-Sheng Yang、Adam Beard、Huaming Sheng、Li-Kang Zhang、Roy Helmy
    DOI:10.1021/acs.oprd.5b00312
    日期:2016.1.15
    The ICH has strict guidelines for limiting the presence of potentially mutagenic impurities (PMIs) in marketed drugs. Therefore, it is important to fully characterize and quantitate all possible PMIs that could arise during the process of synthesizing and developing a drug. Two important and prevalent examples of PMIs are compounds containing N-oxide and nitro functional groups. TiCl3 derivatization is an established method for determining the presence or absence of N-oxide metabolites by reduction to the corresponding amine. In this study, we demonstrate a novel application of TiCl3 reduction combined with high-resolution UHPLC/HRMS to analyze PMIs. The results indicate that a variety of N-oxide- and nitro-containing compounds can be readily characterized by this facile platform method. In addition, we show that this chemical derivatization method can be utilized to enhance the ionization of nitro-containing compounds for LC/MS analysis.
查看更多